![](https://nordicbioproducts.fi/wp-content/uploads/2024/06/nbg_lappeenrantaproductionfacility-2000x1180.jpg)
Press releases
June 26th, 2024
Nordic Bioproducts Group Receives Pharmaceutical Industry’s EXCiPACT® Certification for MCC Production at New Lappeenranta Facility
Read more
Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials with a high processing value. The purpose of the investment is to strengthen Nordic Bioproducts Groups’s (NBG) growth and expansion.
Read the full story here.